Pharma A/p/g/g Flashcards
1
Q
Medications that may trigger Psoriasis
A
- Lithium
- Beta-blockers
- antimalarials
- angiotensin-converting enzyme inhibitor
- NSAIDs
2
Q
Hydrating Agents
A
- Water-in-oil prep
- oatmeal products
- ointments
3
Q
Anti-pruitics
A
- Antihistamines 1st Gen
- Antidepressants
4
Q
Calcineurin Inhibitors
A
- Cyclosporine
- Voclosporine
- Tacrolimus
- Pimecrolimus
5
Q
Anti-TNF Drugs
A
- Entanercept
- Infliximab
- Adalimumab
- Certolizumab pegol
- Golimumab
6
Q
Cyclosporine
A
- suppress t-cell activation
- inhibit transcription of IL-2
- inhibit production of cytokines
- immunosuppression
- Nephrotoxic, Cancer risk
7
Q
Tazarotene
A
- relative selectivity for RARb and RARg
- inhibit keratinocyte proliferation and differentiation
8
Q
Mycophenolate
A
- inhibits inosine monophosphate dehydrogenase
- inhibit proliferation of T- and B- lymphocytes
9
Q
Calcipotriene
A
- slows skin cell growth
- synthetic vitamin D3
10
Q
SE
Calcipotriene
A
- skin irritation, sting, burn
- Less common: dry skin, peeling, rash, dermatitis, worsening of psoriasis
11
Q
Anthralin
A
- reduces rapid growth of skin cells associated with plaque psoriasis
12
Q
Alefacept
A
- Binds to CD2 and inhibit leukocyte function antigen 3 and CD2 interaction
- Prevent antigen binding and T-cell activation
- Destroys T-lymph causing plaque
- increase activity of NK cells
13
Q
SE
Alefacept
A
- Sore throat, dizziness, cough, nausea, itch, muscle pain, chill
- injection site pain/ swelling
- Serious: lymphopenia, infection, cancer, allergic rxn
- Hepatic: elevate AST/ALT, fatty infiltrate, hepatitis
- avoid if blood lymphocyte < 250/ml
14
Q
IL-2
A
Necessary for T-cell activation
15
Q
Calcineurin inhibitors
A
- bind to immunophilins
- blocks effect of calcineurin
- leads to reduced IL-2 and T-cell prolif
16
Q
Tacrolimus
A
- indicated for moderate to severe atopic dermatitis
- children > 2 y.o. (0.03%)
- nephrotoxic, hemato/oncological
17
Q
Pimecrolimus
A
- mild atopic dermatitis
- > 2 y.o.
- Nephrotoxic, neospasms/infection
18
Q
Acitretin
A
- transcription regulator
- reduce keratinocytes differentiation
- slows cell reproduction
- reduce epidermal hyperplasia
19
Q
Target
TNF-alpha
A
- Certolizumab pegol
- entanercept
- adalimumab
- infliximab
- golimumab
20
Q
Target
IL-12 and 23
A
Ustekinumab
21
Q
Target
IL-23
A
- tildrakizumab
- guselkumab
- ## risankizumab
22
Q
Target
IL-17
A
- secukinumab
- ixekizumab
23
Q
SE
Ustekinumab
A
- prevent T-cell activation
- NVD, headache, tiredness
- Upper resp. infection
- flu symptoms
- ulcer, syncope, body pain/swell
- cerebal edema
- allergic rxn
24
Q
Interferon-gamma
A
- produced by activated lymphocytes
- antiviral activity
- immunoregulatory fuction
- In psoriasis, effects are absent
25
IL-17
- induced by IL-23
- Pro-inflammatory cytokine
- acts synergistically with TNF-a and IL-1
- potent mediator in delayed-type rxn
- recruits monocytes and neutrophils
26
# IL-17A blocker
Antibody that binds to inflammation-causing protein
- ixekizumab
- brodalumab
- secukinumab
27
# IL-17A Blocker
Antibody against IL-17A
- secukinumab
28
Guselkumab
- selectively inhibits IL-23
- supress inflammatory and immune response
29
# SE
Guselkumab
- NVD, headache, stomach flu
- Upper resp. infection, fungal skin infection, herpes simplex infection
- Inj site rxn
- joint pain
30
# TYK2 Inhibitor
Deucravacitinib
- selective to TYK2 pathway
- fewer risks
- inhibit immune response and inflammatory proteins
31
# SE
Deucravacitinib
- NVD, fever, sweat, chill, muscle pain
- SoB, stomach pain
- Frequent/painful urination
- Painful skin/ sores
32
Inhibition of PDE4
- increase cAMP, activate PKA
- PKA inhibits Nuclear factor of activated cells
33
Apremilast
- PDE4 inhibitor
- reduce TNF-a, upregulate IL-10
34
# SE
Apremilast
- Headache, back pain, fatigue
- NVD
- URI, nasopharyngitis
- serious: weight loss, severe NVD, depression, suicidal tendencies
35
Medication that trigger acne
- anabolic steroids
- sex steroids
- corticosteroids
- Isoniazids
- Lithium
- Phenytoin
- oral contraceptives
36
Mild Acne
- gentle cleanse
- benzoyl peroxide
- Low conc. SA
37
Moderate- Severe Acne
- Benzoyl peroxide
- Draining large pimples
- topical antibiotics
- Retinoids
- Azelaic acid
38
Retinoic Acid
- increase proliferation of cells
- follicle epithelial turnover
- decrease in microcomedones
- shedding of corneocytes
39
Topical Retinoid SE
- dryness and irritation
- skin color change
- photosensitivity
- red, swelling, crusting, blistering, eruptions
- teratogenic
40
Azelaic acid
- treat rosacea and severe acne
- competitive inhibitor of mitochondrial oxidoreductases
- bacteriostatic
- anti-keratinizing
41
# SE
Azelaic acid
- burning feeling
- peeling skin
- dryness, redness
- Rare: blister/flaking of skin, iriitation + swelling, tightness/pain in joints, hives, fever, difficulty breathing
42
Dapsone
- blocks complex that forms folate
- decrease in folate availability
43
Tetracycline
- block access of amino TRNA complex
44
Erythromycin / Azithromycin
- blocks translocation
45
SMTH-TMP
- blocks PABA
46
Clindamycin
- Blocks peptide synthesis
47
# Gout
Probenecid SE
* GI irritation
* Allergic dermatitis
* nephrotic syndrome
* anemia
48
Allopurinol SE
* exacerbate acute gouty attack
* GI distress
* neuritis
* hepatotoxic, interstitial nephritis
* Rare: necrotising vasculitis, marrow depression, SJS, cataracts
49
Febuxostat SE
- NVD
- rash
- arthralgia
- increased LFT's
50
Pegloticase SE
* gout flare
* nephrothiasis
* NVD
* rash
* upper respiratory infection
* dizziness, anemia, fatigue, hypertension
* Delayed uticarial injection site rxn
51
Lesinurad SE
- NVD, headache, increased creatinine, GERD, influenza
- BBW, risk of renal failure
52
# (-olol)
Beta-blockers SE
| may develop tolerance
* ocular stinging
* redness, photophobia, dry eyes
* uveitis
* ocular inflammation
53
Adrenergic agonist (epinephrine, dipivifrin)
* headache, tachycardia, arrythmias
* HTN,
* anxiety, tremor, sweating nervousness
54
# ALPHA 2 ADRENERGIC AGONIST
Apraclonidine
Brimonidine
* dryness
* ocular irritation
* headache, fatigue, sedation
* Risk: dizziness, Hypotension
55
# (-zolamide)
Carbonic Anhydrase Inhibitor SE
* NVD, metallic taste, cramps, GI distress
* malaise, fatiue, weight loss,
* decreased libido, anorexia
* renal stone, renal failure, metabolic acidosis
* depression, dementia
56
Cholinergic Agonist
- ocular (varied)
- systemic: HTN, NVD, tachycardia, bronchospasm, pulmonary edema,
- CI: asthma, retinal detachment, bradycardia, parkingson's, heart failure, epilepsy
57
# (-prost)
Prostaglandin Analogs SE
- mild burning, hyperemia, itching
- blurred vision, eye pain/discomfort
- Darker eye pigmentation
- thicker eyelashes
58
Lanoprostene Bunod
- eye redness + discharge, eye irritation, eye pain
- change in lashes, pain upon instilling drops